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Summary 
 
Intestinal hexose absorption and gluconeogenesis have been studied in relation to refeeding 
after two different fasting phases: a long period of protein sparing during which energy 
expenditure is derived from lipid oxidation (phase II), and a later phase characterized by a 
rise in plasma corticosterone triggering protein catabolism (phase III). Such a switch in 
body fuel uses, leading to changes in body reserves and gluconeogenic precursors could 
modulate the intestinal gluconeogenesis and glucose transport. The gene and protein levels, 
and the cellular localization of the sodium-glucose cotransporter SGLT1, and of GLUT5 
and GLUT2 as well as that of the key gluconeogenic enzymes phosphoenolpyruvate 
carboxykinase (PEPCK) and glucose-6-phosphatase (Glc6Pase) were measured. PEPCK 
and Glc6Pase activities were also determined. In phase III fasted rats, SGLT1 was 
upregulated and intestinal glucose uptake rates were higher than in phase II fasted and fed 
rats. PEPCK and Glc6Pase mRNA, protein levels and activities also increased in phase III. 
GLUT5 and GLUT2 were downregulated throughout the fast, but increased after 
refeeding, with GLUT2 recruited to the apical membrane. The increase in SGLT1 
expression during phase III may allow glucose absorption at low concentrations as soon as 
food is available. Furthermore, an increased epithelial permeability due to fasting may 
induce a paracellular movement of glucose. In the absence of intestinal GLUT2 during 
fasting, Glc6Pase could be involved in glucose release to the blood stream via membrane 
trafficking. Finally, refeeding triggered GLUT2 and GLUT5 synthesis and apical 
recruitment of GLUT2, to absorb larger amounts of hexoses.  
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Introduction 
 
Glucose is transferred across the brush-border membrane of enterocytes either by an 
energy-dependent sodium-dependent glucose cotransporter 1 (SGLT1) when its 
concentration does not exceed 30-50mM, or by diffusion at a higher concentration 
(Fullerton & Parsons, 1956; Debnam & Levin, 1975a; Lostao et al., 1991). Fructose is 
transported by the facilitative transporter GLUT5 (Rand et al., 1993). At the baso-lateral 
membrane of the cell, hexoses exit to the blood stream by facilitated diffusion via GLUT2 
(Thorens et al., 1990). GLUT2 can also be recruited to the brush-border membrane where 
it contributes to the absorption of glucose from the lumen (Kellett & Helliwell, 2000; 
Kellett, 2001).  
Adult rats fed diets enriched in glucose show a specific upregulation of glucose transport 
activity in both the brush border membrane (Ferraris et al., 1992) and the basolateral 
membrane (Cheeseman & Maenz, 1989). Also, during dietary restriction, the affinity of the 
carriers for sugars increases (Debnam & Levin, 1975b) and a 72h-fast causes an overall 
increase in glucose absorption in rats (Das et al., 2001). 
Fasting also induces an increase in gluconeogenesis in the small intestine which produces 
up to one third of endogenous glucose after 72 hours of fasting (Mithieux et al., 2004). The 
main precursors of gluconeogenesis in the small intestine are glutamine and glycerol to a 
much lesser extent (Croset et al., 2001). Two key gluconeogenic enzymes, the rate-limiting 
phosphoenolpyruvate-carboxykinase (PEPCK, EC 4.1.1.32) involved in glucose 
production from glutamine, and glucose-6-phosphatase (Glc6Pase, EC 3.1.3.9) which 
catalyzes the dephosphorylation of glucose-6-phosphate to glucose, are expressed in the 
small intestine and are upregulated in 48h fasted rats (Rajas et al., 1999, 2000).  
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Studies on intestinal hexose absorption and on intestinal gluconeogenesis during food 
deprivation have hitherto been restricted to relatively short periods of fasting and have 
never been carried out according to the metabolic changes occurring through fasting. 
However, during fasting, the glucose sources and gluconeogenic precursors vary in relation 
with changes in body fuels utilization characterizing three distinct phases (Goodman et al., 
1980; Le Maho et al., 1981): after a rapid period of adaptation marked by the depletion of 
glycogen reserves (phase I), lipid stores are progressively oxidized whereas body proteins 
are efficiently spared (phase II). The later fasting phase is characterized by both a strong 
increase in protein utilization as a substitute fuel for lipids (phase III) and a rise in plasma 
corticosterone level. Also, changing hormone levels through fasting may play a role in the 
regulation of gluconeogenic enzymes in the small intestine and on intestinal glucose 
transporters. The three phases have been first observed during fasting in penguins and rats 
(Le Maho et al., 1981; Cherel & Le Maho, 1991a). Commonly, well-nourished humans do 
never reach a phase II fasting during interprandial periods. It is however noteworthy that 
fasting humans exhibit metabolic and hormonal changes characteristic of a phase II fast 
after a few days of fasting (Cahill et al., 1966). In extremely malnourished humans like 
anorexic or cancer patients, a high urinary nitrogen loss and a low plasma fatty acid 
concentration, both characteristic of a phase III fasting, have been observed (Rigaud et al., 
2000). In obese patients submitted to total fasting, it has been shown that refeeding with a 
high carbohydrate diet was efficient and beneficial (Leiter & Marliss, 1983), but the 
intestinal cellular mechanisms implicated remain unknown. 
The aim of this work, therefore, is to examine intestinal glucose absorption and production 
during distinct fasting phases and refeeding characterized by metabolic and hormonal 
changes (Goodman et al., 1980; Le Maho et al., 1981; Koubi et al., 1991; Challet et al., 
1995).  
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Intestinal SGLT1, GLUT5 and GLUT2 gene and protein expressions were measured in 
phase II and phase III fasted rats. Since the energy load could first come from carbohydrate 
absorption after refeeding (Das et al., 2001), gene and protein expressions of these 
transporters were also studied in 2, 6 and 24h refed rats following either phase II, or phase 
III. To further examine glucose absorption, intestinal glucose uptakes were measured in 
vivo in normally-fed, phase II and phase III fasting rats. Finally, intestinal gluconeogenesis 
was studied during phase II, during which the glycerol released from lipid oxidation may 
be the main gluconeogenic precursor, and during phase III, when the delivery of amino 
acids to the gluconeogenic tissues increased markedly. In that way, PEPCK and Glc6Pase 
gene expressions, protein levels and activities were examined during the fasting phases and 
after refeeding. 
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Methods 
 
Animals 
Male Wistar rats weighing 300g were obtained from Iffa-Credo (Lyon, France). Animals 
were housed individually in leucite cages with a wire mesh floor to prevent coprophagia, 
and maintained at 23°C with a 12-hour light period. They were fed a standard diet (A03 
pellets from UAR, Epinay-sur-Orge, France) and had free access to water throughout the 
experiments. They were weighed every day between 9.00 and 10.00h a.m. Our 
experimental protocol followed the CNRS guide for care and use of laboratory animals. 
 
Experimental procedures 
After one week acclimatization, rats were killed as control animals (Ctrl), whereas the 
other rats were food deprived. The fasting phases (II, III) were determined by calculating 
the specific daily rate of body mass loss dM/Mdt (g/kg/day) for each animal (dM 
represents the loss of body mass during dt=t1-t0 and M is the rat body mass at t0). The 
phase II fasting period lasting between one and six days (for 300g rats), a first group of rats 
was killed in the fourth day in phase II (P2r0, n=15). Three other groups were refed during 
2h (P2r2, n=5), 6h (P2r6, n=5), or 24h (P2r24, n=5) following phase II, and then killed. 
Four additional groups continued fasting until the second day of phase III, reaching on 
average eight days of fasting. Such a fast is still reversible since animals in phase III can be 
successfully refed at this time, just as well after a spontaneous fast in wild animals as after 
an experimental fast (Le Maho et al., 1976, 1981; Cherel & Le Maho, 1991a). In our study, 
one group was killed in phase III without refeeding (P3r0, n=15), whereas the three others 
 
 7
were killed after refeeding for 2h (P3r2, n=5), 6h (P3r6, n=5), or 24h (P3r24, n=5) 
following phase III.  
The animals were killed between 9.00 and 10.00 a.m. The jejunum was removed, weighed, 
and cut into segments. These segments were then treated separately depending on the 
analysis considered. 
 
Plasma parameters and intestinal enzyme activities 
Blood samples were collected immediately after sacrifice to measure plasma 
concentrations of urea, corticosterone, insulin and glucose in all experimental groups. 
Plasma urea was determined with an Urea Nitrogen Kit (Sigma Diagnostics, St Louis, 
USA) and plasma concentrations of corticosterone and insulin with Enzyme Immunoassay 
Kits [Assay Designs (Ann Arbor, USA) and Eurobio (Les Ulis, France), respectively]. 
Glycemia was measured using the glucose oxydase-peroxydase technique. 
Glc6Pase activity was determined in the small intestinal mucosa as described by Rajas et 
al. (1999), and the Jomain-Baum and Schramm (1978) protocol was followed to measure 
PEPCK activity.  
 
Northern blot analysis 
Total RNA from duodenal and jejunal mucosa was isolated by the method of Chomczynski 
and Sacchi (1987). Of total RNA, 5µg was electrophoresed per lane in an agarose gel. 
After electrophoresis, RNA was transferred to a nylon membrane (Roche Diagnostics, 
Mannheim, Germany) by vacuum blotting and then fixed on the membrane by UV light. 
Blots were probed with specific digoxigenin-end-labeled (5') antisense oligonucleotide 
probes (Eurogentec, Seraing, Belgium) using the method of Trayhurn et al. (1995). The 
following probes were used: 5’-TGCCAGTCCCCCTGTGATGGTGTAAAGGGCGG-3’ 
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for SGLT1 (GenBank D16101), 5’-GGACTGGGCCCCACGGCGTGTCCTATGACGTA-
3’ for GLUT5 (GenBank L05195), 5’-
CCGCCCCGCCTTCTCCACAAGCAGCACAGAGA-3’ for GLUT2 (GenBank J03145), 
5’-GGGTCAGCTCGGGGTTGCAGGCCCAGTTGTTG-3’ for PEPCK (GenBank 
XM_342593), 5’-CGGGACAGACAGACGTTCAGCTGCACAGCCCA-3’ for Glc6Pase 
(GenBank U07993). Slot-blots were stripped and re-probed with an 18S rRNA probe to 
correct for variations in RNA loading or blotting. The blots were analyzed by densitometry 
using Scion Image Software. 
 
Western blot analysis 
Total duodenal and jejunal proteins were isolated from the mucosa after centrifugation 
(90min, 30000g) in 10vol. (wt./vol.) ice-cold sample buffer [10mM Tris-HCl, 10% SDS, 
15mg/mL DTT, 1% protease inhibitor cocktail (Sigma) pH 7.4], whereas the plasma 
membrane fractions were isolated by discontinuous sucrose density gradient centrifugation 
as described previously (McCartney & Cramb, 1993). Protein concentrations were 
determined by the Bicinchoninic Acid method. Western blotting was conducted using 
standard techniques (Hames, 1996). Proteins (25μg per lane) were separated by SDS-
PAGE using 7% poly-acrylamide gels and electroblotted onto PVDF membranes before 
immunodetection processing. The membranes were incubated with the primary antibody 
[rabbit anti-rat SGLT1, Glut5, Glut2 (Chemicon, Temecula, USA), sheep anti-rat PEPCK 
(generously provided by Dr. D. K. Granner), rabbit anti-rat Glc6Pase (generously provided 
by Dr. G. Mithieux)]. Control blots were also run simultaneously using equivalent 
dilutions of either pre-immune serum or immune serum pre-incubated with the peptide 
antigen. Membranes were finally incubated with an alkaline phosphatase-conjugated 
secondary antibody and the bound antibodies were visualized by incubating the blots in 
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BCIP-NBT (Chemicon). The level of immunoreactivity was then measured as peak 
intensity using an image capture and analysis system (Scion Image Analysis). Results were 
expressed as relative densitometric units, normalized to the values of Ponceau-stained blots 
to account for any differences in protein loading among lanes. 
 
Immunohistochemistry 
Formalin-fixed intestinal samples embedded in paraffin were cut 6-µm-thick and collected 
on poly-L-lysine-coated slides. Sections were cleared of paraffin, rehydrated and pre-
incubated with a blocking solution containing normal goat serum. Sections were then 
incubated with the primary antibody (rabbit anti-rat SGLT1, Glut5, Glut2 and Glc6Pase) 
and finally, with Alexa Fluor-labelled goat anti-rabbit IgG (Molecular Probes, Eugene, 
USA). As controls, we used primary antibodies pre-absorbed with the respective peptides 
and preimmune serum. Sections were examined with a fluorescent microscope (Zeiss 
Axioplan 2). 
 
Glucose uptake measurements 
Glucose uptake rate into the small intestine was determined by using the in vivo perfused 
intestinal segments technique. Normally-fed and phase II and phase III fasted rats were 
anesthetized prior to surgery using IP sodium pentobarbital (60mg/kg body mass) and 
placed on a heated (37°C) surgical table. After performing a laparotomy, the small 
intestine was isolated and the luminal contents removed by gently flushing with saline 
solution at 37°C. An intestinal loop was cannulated and a recirculating perfusion was 
started at a flow rate of 2mL/min with 10mL saline solution at 37°C containing 5mM 
glucose. The animals were killed after an absorptive period of 20min. The small intestine 
was excised and the mucosa was scraped free of the underlying tissue and weighed. 
Glucose concentration was estimated in the luminal content using a glucose oxydase-
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peroxydase kit (Roche Diagnostics). The absorption rate was calculated from the 
difference between the total amount of glucose injected initially and that recovered after 
the end of experiment. Blood glucose concentration was also measured before and after 
luminal perfusion.  
 
Statistical analysis 
Data are presented +/- SEM. Statistical comparisons of experimental data were performed 
by one-way and two-way analysis of variance (ANOVA) and Tukey post-hoc test by using 
the software Sigmastat (Jandel). The level of statistical significance was set at P<0.05.
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Results 
 
Body mass loss 
The calculation of the specific daily rate of body mass loss dM/Mdt (g/kg/day) permitted 
the determination of the three fasting phases and a daily monitoring of the physiological 
status for each animal through fasting (figure 1). With this monitoring, all the animals 
survive the prolonged starvation procedure and can be successfully refed. The first fasting 
phase (phase I) lasted only a few hours and was characterized by a rapid decrease in 
dM/Mdt. The specific daily body mass loss then reached a steady rate (approximately 
55g/kg/day) representing phase II and finally, strongly increased which was characteristic 
of phase III. 
 
Plasma parameters 
Plasma corticosterone was 375- and 29-fold higher in phase III fasted (P3r0) than in 
controls and P2r0 rats, respectively (table I). It diminished after only 2h refeeding.  
Uremia did not vary between control and P2r0 rats (table I). In phase III fasting, plasma 
urea concentration was 3.75- and 3.5-fold higher than in control and P2r0 rats, 
respectively. After refeeding following a phase III, urea concentration progressively 
decreased compared to the P3r0 value.  
Plasma insulin concentration dropped in phase II and phase III fasted rats (table I). It 
increased after 2h refeeding following phase II and after 6h refeeding following phase III 
but remained lower than in the control group even after 24h refeeding. 
Glycemia decreased by 2.5-fold in phase II and by 4.5-fold in phase III fasted rats 
compared to controls (table I). While plasma glucose concentration rapidly increased after 
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only 2h refeeding following phase II, it was still significantly lower in animals refed for 
24h following a phase III than in control animals. 
 
SGLT1 gene and protein expressions 
The level of SGLT1 gene (figure 2A) and protein (figure 2B) expressions did not 
significantly vary between control, phase II fasted and refed rats following phase II. In 
phase III, SGLT1 gene expression increased 1.6- and 2.1-fold compared to the control and 
P2r0 values, respectively. Also, the amount of SGLT1 protein rapidly rose in phase III and 
was more than 3-fold higher than in control and phase II fasted rats. The high level of 
SGLT1 gene expression was maintained in refed animals following phase III, whereas its 
protein amount was lowered to control values. Changes in SGLT1 protein expression 
during fasting and after refeeding could also be observed through immunohistochemical 
labelling. As shown in figure 2C, SGLT1 was highly expressed in the brush border 
membrane of phase III fasted rats. 
 
GLUT5 gene and protein expressions 
While GLUT5 gene expression (figure 3A) did not vary, neither in phase II, nor in phase 
III fasted rats compared to controls, its protein amount (figure 3B) was significantly 
decreased by one half in these animals. The amounts of GLUT5 mRNA and protein were 
higher in rats refed following a phase III than following a phase II fast. GLUT5 
immunolabelling (figure 3C) decreased during fasting, whereas it increased in the apical 
membrane of refed animals following phase III. 
 
GLUT2 gene and protein expressions 
GLUT2 gene expression (figure 4A) was decreased by 3.1- and 2.2-fold in phase II and 
phase III fasted rats, respectively, compared to controls, and its protein (figure 4B) was no 
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more detectable in phase II and phase III fasted rats. After refeeding, the level of GLUT2 
mRNA rapidly increased and the protein was already detected after 2h refeeding following 
either phase II, or phase III. The highest increase in GLUT2 mRNA and protein after 
refeeding could be observed in the P3r2 rats, where the values were no more different than 
the control ones. In control rats, GLUT2 was mainly localized in the enterocytes baso-
lateral membranes (figure 4C). In refed animals following phase III, an intense staining of 
GLUT2 could be observed in the apical membrane. 
 
In vivo glucose uptake measurements 
Glucose absorption rate was expressed per milligram tissue and not per centimetre length, 
since intestinal villi and small intestine diameter were very reduced during fasting. Glucose 
was more absorbed in the small intestine of phase II and phase III fasted rats than of 
normally-fed rats (table II). Expressed per milligram of proteins, the results were virtually 
the same. Compared to normally-fed animals, glucose was 1.3- and 2.1- more absorbed in 
phase II and phase III fasted rats, respectively. The glycemia rose in glucose perfused 
fasted rats but remained still lower than in controls (table II).  
 
PEPCK gene expression, protein level and activity 
PEPCK mRNA (figure 5A) and protein levels (figure 5B) and PEPCK activity (figure 5C) 
did not vary between control, P2r0 and refed rats following phase II. However, a phase III 
fast induced a 4-, 13- and 30-fold increase in PEPCK mRNA, protein level and activity, 
respectively. These values remained still high after 2h refeeding following phase III. In 
these animals, the amount of PEPCK protein was even 2.5- and 32-fold higher compared to 
phase III fasted and control rats, respectively. This increase in PEPCK protein content in 
the P3r2 group was unexpected in regard to the changes in the levels of gene expression 
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and activity and in regard to the values of the other experimental groups. PEPCK protein 
expression then decreased in rats refed 6h following phase III and was lower than in 
controls after 24h refeeding. 
 
Glc6Pase gene expression, protein level and activity 
Glc6Pase gene expression (figure 6A) did not vary between control and phase II fasted 
rats. The phase III fast induced a 10-, 2.3- and 2.1-fold increase in Glc6Pase mRNA, 
protein level (figure 6B) and activity (figure 6D), respectively. In refed animals following 
phase III, Glc6Pase mRNA level and activity decreased to control values, while no 
changes occurred after phase II. In refed animals following both phases, protein abundance 
decreased to levels lower than in controls. In control rats, Glc6Pase appeared to be in the 
epithelial cells along the whole villus axis and in all the intestinal villi (figure 6C). A 
cytoplasmic staining restricted to the apical part of the enterocytes immediately under the 
microvilli could be observed. In phase III fasted rats, the localization was similar but the 
staining appeared more intense. 
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Discussion 
 
To our knowledge, it is the first study to investigate intestinal glucose absorption and 
gluconeogenesis according to body fuel availability. It appeared that during protein 
catabolism (phase III fast), the active way of glucose absorption is induced by an increase 
in SGLT1 in the brush border membrane, whereas the facilitated component of intestinal 
glucose transport is triggered at refeeding by an increase in GLUT2 translocated to the 
apical membrane. The study also shows an increase in intestinal gluconeogenesis during 
the phase III fasting period, during which the gluconeogenic precursors may be amino 
acids coming from protein catabolism, compared to the phase II fasting period, i.e. when 
glycerol may be the main gluconeogenic precursor. 
 
Glucose transport 
While a phase of lipid oxidation (phase II) did not induce any changes in SGLT1 gene and 
protein expressions, their levels were upregulated by a phase of protein catabolism (phase 
III). These results suggest that the metabolic status of phase III fasted rats, rather than the 
duration of fasting, enhanced SGLT1 gene expression and protein synthesis. Such an 
increase in active glucose transporter level may allow intestinal glucose absorption 
immediately after refeeding even at low concentrations. As illustrated by the in vivo 5mM 
glucose uptake measurements, glucose is massively absorbed in the intestine of phase III 
fasted rats. It could involve SGLT1 and can be related to the high level of corticosterone, 
as reported in the normal (Batt & Peters, 1976; Batt & Scott, 1982; Iannoli et al., 1998) 
and in the inflamed small intestine (Sundaram et al., 1999). Noteworthy, in the inflamed 
intestine glucocorticoids are able to restore the levels of SGLT1 (Sundaram et al., 1999). 
However, SGLT1 may not be solely involved in glucose absorption during fasting, since 
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the 5mM glucose solution was also more absorbed during phase II fasting compared to 
normally-fed rats, without any increase in SGLT1 gene and protein expressions. An 
increase in intestinal permeability which allows paracellular movement of macromolecules 
has been observed during fasting and malnutrition (Worthington et al., 1974; Welsh et al., 
1998; Boza et al., 1999) and could therefore also permit glucose absorption during phase II 
and phase III fasting. An increase in glucose absorption during fasting has also been 
previously observed in dogs (Galassetti et al., 1999). Refeeding following the phase III fast 
induced a decrease in SGLT1 protein amount which paralleled the decrease in plasma 
corticosterone concentration. In contrast, the level of SGLT1 mRNA remained unchanged 
after refeeding suggesting a post-transcriptional mechanism of regulation induced by 
refeeding. A post-transcriptional regulation of SGLT1 characterized by a higher stability of 
the mRNA induced by cAMP has already been showed in an in vitro renal model (Peng & 
Lever, 1995). 
The amount of the facilitative hexose transporter GLUT5 protein was lowered during 
fasting and increased during refeeding. This is in accordance with previous studies 
showing that food ingestion involves de novo synthesis of GLUT5 mRNA and protein 
(Ferraris, 2001). However, the levels of mRNA did not parallel the level of protein except 
for the refeeding period following the phase III fast, suggesting that regulation of GLUT5 
is at least partly post-transcriptional. It has been shown previously that the GLUT5 mRNA 
stability is increased by fructose, in part via an increase of the cAMP pathway (Gouyon et 
al., 2003). In our study however, the decrease in GLUT5 protein content in fasting animals 
could be, at least partly, a non specific decrease, since during fasting the whole body 
protein synthesis is reduced (Cherel et al., 1991b). 
The protein and gene expressions of the facilitative glucose transporter GLUT2 were 
downregulated during phase II and phase III fasting and upregulated by refeeding. These 
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changes may be linked to plasma corticosterone, shown to inhibit this transporter in 
stressed rats (Shepherd et al., 2004). In refed rats, GLUT2 was recruited from the baso-
lateral enterocytes membrane to the apical brush border membrane. Recruitment of 
GLUT2 to the apical membrane has been reported in previous studies and is partly 
controlled by the SGLT1-dependent activation of a protein kinase C (Kellett & Helliwell, 
2000; Helliwell et al., 2000a, 2000b). GLUT2 is characterized by a high Km and provides 
a passive component of glucose absorption from the intestinal lumen detectable at high 
concentrations (Kellett, 2001).  
 
Gluconeogenesis 
During the short phase I fasting period, glycogen stores are completely exhausted 
(Goodman et al., 1980; Le Maho et al., 1981). Glucose is then produced by 
gluconeogenesis from various precursors coming essentially from adipose tissue lipolysis 
during phase II (glycerol) and from protein catabolism during phase III. PEPCK and 
Glc6Pase mRNA levels and enzymatic activities have been shown to increase in the small 
intestine in 48h fasted rats and then to reach a plateau after 72h fasting (Mithieux et al., 
2004; Rajas et al., 1999, 2000). In our study, PEPCK and Glc6Pase gene expressions, 
protein levels and activities did not vary during phase II fasting (5 days fasting) compared 
to normally-fed animals. Plasma levels of ketone bodies, which have been shown to inhibit 
specific CoA-dependent enzymes involved in gluconeogenesis in the liver (Balasse et al., 
1967; Kean & Pogson, 1979; Shaw & Wolfe, 1984; Fery et al., 1996) are elevated during 
this fasting phase (Goodman et al., 1980; Belkhou et al., 1991). In phase II fasted rats 
however, plasma insulin (known to inhibit gluconeogenesis) dropped, whereas plasma 
corticosterone (known to stimulate gluconeogenesis) slightly increased. As a whole, these 
effects would lead to a lack of significant change in intestinal gluconeogenesis after a 5-
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day fast (phase II). During a phase III fasting period, the strong increase in 
gluconeogenesis may be a direct consequence of the elevated plasma corticosterone level 
and the decrease in ketone bodies (Goodman et al., 1980; Belkhou et al., 1991) in relation 
to the switch in the gluconeogenic precursors from glycerol to amino acids. 
Glucocorticoids are known to stimulate gluconeogenesis by induction of PEPCK 
(Friedman et al., 1993) and Glc6Pase (Ashmore et al., 1956; Nordlie et al., 1965; Voice et 
al., 1997) gene transcription in the liver. Also, corticosterone induced protein catabolism 
and thereby, the release of gluconeogenic amino acids. During phase III fasting, there is a 
concomitant increase in circulating amino acids and in glucagonaemia (Cherel et al., 
1988), which could stimulate the uptake and conversion of plasma amino acids into 
glucose by the small intestine. Refeeding rapidly induced normalization of 
gluconeogenesis, despite a low glycemia. This might be explained by the rapid decrease in 
the level of plasma corticosterone and by the increase in the level of plasma insulin which 
is known to inhibit the gene expression of the gluconeogenic enzymes in the liver (Barthel 
& Schmoll, 2003). A decrease in Glc6Pase activity to base-line values has been shown 
previously in the liver (Newgard et al., 1984) and in the small intestine (Rajas et al., 1999) 
in rats refed after short fasting periods. Normalization of PEPCK activity is also rapidly 
achieved in the jejunum in these animals (Rajas et al., 2000).  
Finally, the observation of Glc6Pase in the apical part of the enterocytes suggests that this 
enzyme could also be involved in the transepithelial transport of glucose, as shown 
previously (Stumpel et al., 2001; Santer et al., 2003). According to these studies, glucose 
absorbed through SGLT1 is phosphorylated into glucose-6 phosphate before entering the 
endoplasmic reticulum where it is hydrolyzed by Glc6Pase to glucose and phosphate. 
Glucose then re-enters the cytosol and diffuses out of the enterocytes through GLUT2 or is 
released into the blood stream by a membrane traffic pathway. This latter mechanism could 
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permit glucose secretion into the blood when GLUT2 is absent like in phase II and phase 
III fasted rats. 
 
In light of all this data, it appears that energy depletion in relation with body fuel uses and 
gluconeogenic precursors availability increases the ability of the intestine to absorb sugar 
from its lumen and stimulates intestinal gluconeogenesis. A phase II fast, associated with a 
high availability of glycerol as gluconeogenic precursor leads to an impaired ability of the 
small intestine to absorb glucose and to no change in intestinal gluconeogenesis. A phase 
III fast however, associated with a high availability of amino acids used as gluconeogenic 
precursors, leads to an increase in the ability of active glucose absorption. Glucose can 
then, be immediately absorbed at low concentrations at refeeding. At the same time, 
intestinal gluconeogenesis is increased. In the absence of GLUT2, Glc6Pase could also 
play a role in glucose transport through the cell and thereby, in its secretion into the blood 
stream. Finally, refeeding induces facilitative transport, so that large amounts of fructose 
and glucose can be transported from the intestinal lumen to the blood stream.  
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Table I 
 
Plasma corticosterone, urea, insulin and glucose concentrations in control, fasted and refed 
rats 
 Corticosterone 10-7g.L-1 Urea g.L-1 Insulin 10-6g.L-1 Glucose mM 
Ctrl 0.83 ± 0.61a 0.189 ± 0.007a 3.20 ± 0.46a 11.42 ± 0.73a
P2r0 10.77 ± 3.12ab 0.203 ± 0.011a 0.20 ± 0.06b 4.57 ± 0.87b
P2r2 0.51 ± 0.29a 0.319 ± 0.025ab 1.20 ± 0.41bc 9.88 ± 0.72ac
P2r6 1.60 ± 0.72a 0.282 ± 0.014ab 1.31 ± 0.46bc 8.58 ± 0.54cd
P2r24 6.07 ± 2.43ab 0.176 ± 0.015a 1.84 ± 0.31c 9.43 ± 0.27ad
P3r0 311.01 ± 62.69b 0.708 ± 0.068b 0.34 ± 0.11b 2.57 ± 0.31b
P3r2 7.08 ± 1.75ab 0.598 ± 0.067b 0.39 ± 0.13b 3.59 ± 0.27b
P3r6 14.67 ± 5.23ab 0.448 ± 0.009ab 1.33 ± 0.29bc 4.22 ± 0.39b
P3r24 6.78 ± 3.84ab 0.243 ± 0.017ab 1.51 ± 0.26bc 7.51 ± 0.68d
Results are means ± SEM, n=6 rats per group. Within the same column, values with 
different letters are significantly different (P<0.05). 
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Table II:  
 
In vivo glucose uptake measurements and glycemia after 5mM intestinal glucose perfusion 
in control, phase II and phase III fasted rats 
 Ctrl P2r0 P3r0 
Glucose absorption (5mM perfusate) 
(10-4mmol glucose/mg mucosa/min) 
3.03 ± 0.23a 3.91 ± 0.51b 6.29 ± 0.56c
Glycemia mM (not perfused) 11.42 ± 0.73a 4.57 ± 0.87c 2.57 ± 0.31c
Glycemia mM (5mM perfusate) 14.33 ± 2.46b 9.24 ± 0.97d 6.27 ± 1.21d
 
Results are means ± SEM, n=5 rats per group. Values with different letters are significantly 
different (P<0.05). Glucose absorption was compared according to the metabolic status 
(Ctrl, P2r0, P3r0). Glycemia was compared according to the metabolic status (Ctrl, P2r0, 
P3r0) and to the perfusion condition (none, 5mM perfusate). 
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Figure 1: 
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Figure legends 
 
Figure 1: Rate of body mass loss (dM/Mdt, g/kg/day) in fasted rats. Mean ± SEM (n=5). 
 
Figure 2: SGLT1 gene (A) and protein (B) expressions in Ctrl, P2r0 and P3r0 rats and after 
refeeding (P2r2, P2r6, P2r24, P3r2, P3r6, P3r24). The upper panels show representative 
northern (A) and western (B) blots and the lower panels show the densitometric analysis 
(Ctrl to P3r24 from the left to the right). (C) shows SGLT1 immunolocalization in control, 
phase II and phase III fasted rats. The immunofluorescence in the lamina propria is non-
specific. Mean +/- SEM (n=5 per group). 
 
Figure 3: GLUT5 gene (A) and protein (B) expressions in Ctrl, P2r0 and P3r0 rats and 
after refeeding (P2r2, P2r6, P2r24, P3r2, P3r6, P3r24) and GLUT5 immunolocalization (C) 
in control, phase III fasted and 2h refed rats following phase III. Mean +/- SEM (n=5 per 
group). 
 
Figure 4: GLUT2 gene (A) and protein (B) expressions in Ctrl, P2r0 and P3r0 rats and 
after refeeding (P2r2, P2r6, P2r24, P3r2, P3r6, P3r24) and GLUT2 immunolocalization (C) 
in control, phase III fasted and 2h refed rats following phase III. Mean +/- SEM (n=5 per 
group). 
 
Figure 5: PEPCK gene expression (A), protein level (B) and activity (C) in Ctrl, P2r0 and 
P3r0 rats and after refeeding (P2r2, P2r6, P2r24, P3r2, P3r6, P3r24). Mean +/- SEM (n=5 
per group). 
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Figure 6: Glc6Pase gene expression (A), protein level (B) and activity (D) in Ctrl, P2r0 and 
P3r0 rats and after refeeding (P2r2, P2r6, P2r24, P3r2, P3r6, P3r24). (C) shows Glc6Pase 
immunolocalization in control and phase III fasted rats. Mean +/- SEM (n=5 per group). 
 
 
 
